Why would the FDA draw this out so long and create such a huge hoopla by doing so, articles, conferences, blogs etc... all talking about this stock. For a simple rejection?
HEB has been the talk of the bio-pharm investment world for about 3 weeks now.
Makes me wonder, by drawing this out - they increase scrutiny on themselves (the FDA) why do so, if they could have put this to bed about 2 weeks ago - without any noise???
Perhaps, I am just too optimistic, but you have to remember that the FDA is part of the government, a new presidential administration, is always looking for ways to minimize public scrutiny. I certainly believe they didnt draw this out to simply reject it and raise a ruckus...
Perhaps my thought is ridiculous...but i cant help think about it.